IndiaNivesh board approves director reappointments and subsidiary sale

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Board reappointed Rajesh Nuwal as MD for three years and Kaushik Shah as NED
  • Approved sale of 100% stake in subsidiary IndiaNivesh Commodities Private Limited
  • Subsidiary had nil revenue and net worth of ₹387.02 lakh in last financial year
  • Finalized governance documents including Secretarial Audit Report for FY26
  • Authorized NSDL for e-voting and Jajodia & Associates as scrutinizer for AGM
powered bylight_fuzz_icon
49385569

*this image is generated using AI for illustrative purposes only.

IndiaNivesh Limited held its Board of Directors meeting on September 1, 2026. The session approved the reappointment of key leadership roles and authorized the sale of its wholly owned subsidiary, IndiaNivesh Commodities Private Limited (INCPL).

The meeting concluded with the finalization of governance documents for the financial year ended March 31, 2026, and logistical approvals for the upcoming Annual General Meeting (AGM).

Leadership Reappointments

The board considered and approved the reappointment of two senior directors, subject to shareholder approval at the ensuing AGM:

  • Rajesh Nuwal: Reappointed as Managing Director for a further period of three years. The decision was based on the recommendation of the Nomination and Remuneration Committee. Mr. Nuwal is related to Promoter Director Mr. Dinesh Nuwal.
  • Kaushik Jashwantlal Shah: Reappointed as a Non-Executive Director. He retires by rotation at the ensuing AGM and offers himself for re-election.

Subsidiary Sale Approval

A significant agenda item was the approval to sell 100% equity shares held in IndiaNivesh Commodities Private Limited (INCPL).

The subsidiary contributed Nil revenue during the last financial year. Its net worth stood at ₹387.02 lakh as per the disclosed figures. Specific sale terms, including consideration and purchaser identity, are not yet finalized. The board has been authorized to execute the transaction on terms deemed fit and advantageous to the company. The completion of the sale is expected in the near future, subject to shareholder approval at the AGM.

Governance and Compliance

The directors addressed statutory compliance matters for FY26:

  • Took note of the Secretarial Audit Report for the financial year ended March 31, 2026.
  • Approved the draft Board of Directors Report for FY26.

Annual General Meeting Preparations

The session included logistical approvals for the 95th AGM:

  • Appointment of M/s. Jajodia & Associates as Scrutinizer.
  • Engagement of National Securities Depository Limited (NSDL) to provide e-voting facilities.

The outcome was disclosed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Indianivesh

1 Day5 Days1 Month6 Months1 Year5 Years
+6.17%-0.89%+2.91%-20.69%-23.31%0.0%

How will the proceeds from the sale of IndiaNivesh Commodities Private Limited be allocated to strengthen IndiaNivesh Limited's core business or balance sheet?

What strategic rationale drives the divestiture of a subsidiary with nil revenue, and does this signal a broader shift in the company's operational focus?

How might the reappointment of Managing Director Rajesh Nuwal influence the company's strategic direction and promoter-family governance dynamics over the next three years?

IndiaNivesh board to consider Q4 and FY26 results on May 29

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

IndiaNivesh Limited has scheduled a board meeting on May 29, 2026, to approve audited financial results for Q4 and FY26. The trading window is currently closed and will reopen 48 hours after the results are declared.

powered bylight_fuzz_icon
41269651

*this image is generated using AI for illustrative purposes only.

IndiaNivesh Limited will convene a board meeting on May 29, 2026, to consider and approve the audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. The meeting will be held at the company's registered office in Mumbai. This disclosure is critical for shareholders as it will provide a complete assessment of the company's financial performance for the full fiscal year.

The board will also consider any other business with the permission of the chair. In compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has intimated the exchange regarding the meeting schedule.

Consequently, the trading window for dealing in the securities of IndiaNivesh Limited has been closed for directors, officers, and designated employees since April 1, 2026. The window will remain shut until 48 hours after the declaration of the audited financial results for the quarter and year ended March 31, 2026, to prevent insider trading.

Key Meeting Details

Detail Information
Meeting Date May 29, 2026
Agenda Audited Standalone and Consolidated Financial Results for Q4 and FY26
Location Registered Office, Lodha Supremus, Lower Parel, Mumbai
Trading Window Status Closed since April 1, 2026; reopens 48 hours post-result declaration

Historical Stock Returns for Indianivesh

1 Day5 Days1 Month6 Months1 Year5 Years
+6.17%-0.89%+2.91%-20.69%-23.31%0.0%

How are analysts expecting IndiaNivesh's Q4 performance to trend compared to the previous fiscal year?

Will the board declare a final dividend for FY26 alongside the financial results announcement?

What guidance, if any, will the management provide regarding the business outlook for FY27?

More News on Indianivesh

1 Year Returns:-23.31%